Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
10.1016/j.niox.2014.11.006 230 WuD
M., Joseph, R., Hussain Al Kubaish, Z., Mohammad Al-Maskeen, S., & Ali Alokaili, Z
Some preclinical work explores FOXO4-p53-targeting peptides against senescent cancer cells, and the developer has discussed cancer as a research interest, but there is no human evidence that FOXO4-DRI treats cancer
Keep in mind, however, that the market for copper peptides is limited, and the alternatives tend to be much more expensive
Obesity or overweight with diabetes
US$ 23.95
US$ 21.27
US$ 28.27
